Survival analysis revealed that low methylation levels of CD8A were related to worse prognosis in glioma, gastric cancer, and uveal melanoma cohorts but were associated with longer survival outcomes in ovarian cancer and KIRP cohorts (Figure 5B). Here, CD8A is linked to central nervous system cancer.